Back to Rankings

SLGL

Sol-GelC
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
SLGL vs peer average
57/100
SLGL vs. peer average (C vs. C)
Grade spread
A 2 · B 1 · C 1 · D 4 · F 3
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

ABOS is the first available peer comparator.

Small-cap clinical biotech comparator for single-program readout risk, capital markets dependence, and event-driven valuation swings.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerABOSAcumen
SLGL
Sol-Gel
ABOS
Acumen
Grade
C
A
Momentum
68
72
Value
44
42
Sentiment
43
76
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Mixed
Constructive

Grade position vs ABOS

SLGL / ABOS
Grade Position
In line
SLGL vs. peer average (C vs. C)
57/100
Momentum
68
ABOS
Value
44
SLGL
Sentiment
43
ABOS

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs SLGL
1
ABOS
ABOS
A
100/100
-2
2
CGTX
CGTX
C
60/100
Even
3
KPTI
KPTI
B
80/100
-1
4
ALXO
ALX Oncology Holdings Inc Common
F
20/100
+2
5
INDP
Indaptus Therapeutics Inc Common
D
40/100
+1
ABOS is the first peer returned for this comparison set.